(Q40022307)
Statements
EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines (English)
Tracey A Haigh
Xiaorong Lin
Hui Jia
Edwin P Hui
Alan B Rickinson